Latest filing published 04 Jun 2026 for Bioventus Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Philip G. Cowdy (board member) discloses dealings in Bioventus Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 11 February 2022 and the latest from 2 June 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 4 June 2026: an option exercise, in Bioventus Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations